These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Effect of eukaryotic expression plasmid DNA methyltransferase gene on methylation status and transcription level of DNA mismatch repair genes in human colon cancer cell line]. Lu R; Fang JY; Zhu HY; Chen YX; Cheng ZH; Li EL Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1014-7. PubMed ID: 15312538 [TBL] [Abstract][Full Text] [Related]
24. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer. Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039 [TBL] [Abstract][Full Text] [Related]
25. DNA mismatch repair protein expression and microsatellite instability in primary mucosal melanomas of the head and neck. Marani C; Alvino E; Caporali S; Vigili MG; Mancini G; Rahimi S Histopathology; 2007 May; 50(6):780-8. PubMed ID: 17493242 [TBL] [Abstract][Full Text] [Related]
26. Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables. Johannsdottir JT; Bergthorsson JT; Gretarsdottir S; Kristjansson AK; Ragnarsson G; Jonasson JG; Egilsson V; Ingvarsson S Anticancer Res; 1999; 19(3A):1821-6. PubMed ID: 10470121 [TBL] [Abstract][Full Text] [Related]
27. Defective DNA mismatch repair in long-term (> or =3 years) survivors with pancreatic cancer. Maple JT; Smyrk TC; Boardman LA; Johnson RA; Thibodeau SN; Chari ST Pancreatology; 2005; 5(2-3):220-7; discussion 227-8. PubMed ID: 15855819 [TBL] [Abstract][Full Text] [Related]
28. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. Fallik D; Borrini F; Boige V; Viguier J; Jacob S; Miquel C; Sabourin JC; Ducreux M; Praz F Cancer Res; 2003 Sep; 63(18):5738-44. PubMed ID: 14522894 [TBL] [Abstract][Full Text] [Related]
29. Conditional nuclear localization of hMLH3 suggests a minor activity in mismatch repair and supports its role as a low-risk gene in HNPCC. Korhonen MK; Raevaara TE; Lohi H; Nyström M Oncol Rep; 2007 Feb; 17(2):351-4. PubMed ID: 17203173 [TBL] [Abstract][Full Text] [Related]
30. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550 [TBL] [Abstract][Full Text] [Related]
31. hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037 [TBL] [Abstract][Full Text] [Related]
32. Molecular basis of HNPCC: mutations of MMR genes. Papadopoulos N; Lindblom A Hum Mutat; 1997; 10(2):89-99. PubMed ID: 9259192 [TBL] [Abstract][Full Text] [Related]
33. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation. Plaschke J; Krüger S; Pistorius S; Theissig F; Saeger HD; Schackert HK Int J Cancer; 2002 Feb; 97(5):643-8. PubMed ID: 11807791 [TBL] [Abstract][Full Text] [Related]
34. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Catto JW; Xinarianos G; Burton JL; Meuth M; Hamdy FC Int J Cancer; 2003 Jul; 105(4):484-90. PubMed ID: 12712438 [TBL] [Abstract][Full Text] [Related]
35. Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in salivary gland tumors. Castrilli G; Fabiano A; La Torre G; Marigo L; Piantelli C; Perfetti G; Ranelletti FO; Piantelli M J Oral Pathol Med; 2002 Apr; 31(4):234-8. PubMed ID: 12076327 [TBL] [Abstract][Full Text] [Related]
36. The role of mismatch repair in small-cell lung cancer cells. Hansen LT; Thykjaer T; Ørntoft TF; Rasmussen LJ; Keller P; Spang-Thomsen M; Edmonston TB; Schmutte C; Fishel R; Petersen LN Eur J Cancer; 2003 Jul; 39(10):1456-67. PubMed ID: 12826050 [TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939 [TBL] [Abstract][Full Text] [Related]
38. Mismatch repair and treatment resistance in ovarian cancer. Helleman J; van Staveren IL; Dinjens WN; van Kuijk PF; Ritstier K; Ewing PC; van der Burg ME; Stoter G; Berns EM BMC Cancer; 2006 Jul; 6():201. PubMed ID: 16879751 [TBL] [Abstract][Full Text] [Related]
39. ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage. Luo Y; Lin FT; Lin WC Mol Cell Biol; 2004 Jul; 24(14):6430-44. PubMed ID: 15226443 [TBL] [Abstract][Full Text] [Related]
40. Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair. Oki E; Oda S; Maehara Y; Sugimachi K Oncogene; 1999 Mar; 18(12):2143-7. PubMed ID: 10321739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]